Prediction of the wine polyphenol metabolic space: An application of the Phenol-Explorer database

Molecular Nutrition and Food Research

Volumn 58, Issue 3, 2014, Pages 466-477

  Boto Ordóñez, María ^a,b   Rothwell, Joseph A ^c   Andres Lacueva, Cristina ^a,d   Manach, Claudine ^e,f   Scalbert, Augustin ^c   Urpi Sarda, Mireia ^a,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Fundacio Clinic Per a la Recerca Biomedica   (Spain)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d FUN C FOOD   (Spain)

^e CRNH AUVERGNE   (France)

^f UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Biological samples; Pathway; Phenol Explorer; Polyphenol metabolic profile; Wine

Indexed keywords

POLYPHENOL;

ANALYSIS; ANIMAL; BLOOD; CHEMICAL DATABASE; FACTUAL DATABASE; HUMAN; METABOLISM; URINE; WINE;

ANIMALS; DATABASES, CHEMICAL; DATABASES, FACTUAL; HUMANS; POLYPHENOLS; WINE;

EID: 84897638157     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300411     Document Type: Article

References (100)

1. The Wine Institute. Available from: http://www.wineinstitute.org.
2. Renaud, S., de Lorgeril, M., Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339, 1523-1526.
3. Chiva-Blanch, G., Urpi-Sarda, M., Llorach, R., Rotches-Ribalta, M. et al., Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial. Am. J. Clin. Nutr. 2012, 95, 326-334.
4. Arranz, S., Chiva-Blanch, G., Valderas-Martinez, P., Medina-Remon, A. et al., Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients 2012, 4, 759-781.
5. Guilford, J. M., Pezzuto, J. M., Wine and health: a review. Am. J. Enol. Vitic. 2011, 62, 471-486.
6. Chiva-Blanch, G., Urpi-Sarda, M., Ros, E., Arranz, S. et al., Dealcoholized red wine decreases systolic and diastolic blood pressure and increases plasma nitric oxide: short communication. Circ. Res. 2012, 111, 1065-1068.
7. Chiva-Blanch, G., Urpi-Sarda, M., Ros, E., Valderas-Martinez, P. et al., Effects of red wine polyphenols and alcohol on glucose metabolism and the lipid profile: a randomized clinical trial. Clin. Nutr. 2012, 32, 200-206.
8. Queipo-Ortuno, M. I., Boto-Ordonez, M., Murri, M., Gomez-Zumaquero, J. M. et al., Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am. J. Clin. Nutr. 2012, 95, 1323-1334.
9. Manach, C., Williamson, G., Morand, C., Scalbert, A. et al., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81, 230S-242S.
10. Manach, C., Scalbert, A., Morand, C., Remesy, C. et al., Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
11. Scalbert, A., Manach, C., Morand, C., Remesy, C. et al., Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287-306.
12. Verzelloni, E., Pellacani, C., Tagliazucchi, D., Tagliaferri, S. et al., Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites. Mol. Nutr. Food Res. 2011, 55(Suppl 1), S35-S43.
13. Calamini, B., Ratia, K., Malkowski, M. G., Cuendet, M. et al., Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem. J. 2010, 429, 273-282.
14. Lasa, A., Churruca, I., Eseberri, I., Andres-Lacueva, C. et al., Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes. Mol. Nutr. Food Res. 2012, 56, 1559-1568.
15. Urpi-Sarda, M., Zamora-Ros, R., Lamuela-Raventos, R., Cherubini, A. et al., HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans. Clin. Chem. 2007, 53, 292-299.
16. Vitaglione, P., Sforza, S., Galaverna, G., Ghidini, C. et al., Bioavailability of trans-resveratrol from red wine in humans. Mol. Nutr. Food Res. 2005, 49, 495-504.
17. Bell, J. R. C., Donovan, J. L., Wong, R., Waterhouse, A. L. et al., (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am. J. Clin. Nutr. 2000, 71, 103-108.
18. Donovan, J. L., Bell, J. R., Kasim-Karakas, S., German, J. B. et al., Catechin is present as metabolites in human plasma after consumption of red wine. J. Nutr. 1999, 129, 1662-1668.
19. Caccetta, R. A. A., Croft, K. D., Beilin, L. J., Puddey, I. B., Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am. J. Clin. Nutr. 2000, 71, 67-74.
20. Scalbert, A., Andres-Lacueva, C., Arita, M., Kroon, P. et al., Databases on food phytochemicals and their health-promoting effects. J. Agric. Food Chem. 2011, 59, 4331-4348.
21. Rothwell, J. A., Urpi-Sarda, M., Boto-Ordonez, M., Knox, C. et al., Phenol-Explorer 2.0: a major update of the Phenol-Explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals. Database 2012, 2012, doi: 10.1093/database/bas031.
22. Neveu, V., Perez-Jimenez, J., Vos, F., Crespy, V. et al., Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database, 2010, 2010, doi:10.1093/database/bap024.
23. Grun, C. H., van Dorsten, F. A., Jacobs, D. M., Le Belleguic, M. et al., GC-MS methods for metabolic profiling of microbial fermentation products of dietary polyphenols in human and in vitro intervention studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 871, 212-219.
24. Forester, S. C., Waterhouse, A. L., Metabolites are key to understanding health effects of wine polyphenolics. J. Nutr. 2009, 139, 1824S-1831S.
25. Kern, S. M., Bennett, R. N., Needs, P. W., Mellon, F. A. et al., Characterization of metabolites of hydroxycinnamates in the in vitro model of human small intestinal epithelium caco-2 cells. J. Agric. Food Chem. 2003, 51, 7884-7891.
26. Moridani, M. Y., Scobie, H., Salehi, P., O'Brien, P. J., Catechin metabolism: glutathione conjugate formation catalyzed by tyrosinase, peroxidase, and cytochrome p450. Chem. Res. Toxicol. 2001, 14, 841-848.
27. Gonthier, M. P., Cheynier, V., Donovan, J. L., Manach, C. et al., Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. J. Nutr. 2003, 133, 461-467.
28. Gonthier, M. P., Donovan, J. L., Texier, O., Felgines, C. et al., Metabolism of dietary procyanidins in rats. Free Radic. Biol. Med. 2003, 35, 837-844.
29. Baba, S., Osakabe, N., Natsume, M., Muto, Y. et al., Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats. J. Agric. Food Chem. 2001, 49, 6050-6056.
30. Abd El Mohsen, M. M., Kuhnle, G., Rechner, A. R., Schroeter, H. et al., Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic. Biol. Med. 2002, 33, 1693-1702.
31. Gonthier, M. P., Verny, M. A., Besson, C., Remesy, C. et al., Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J. Nutr. 2003, 133, 1853-1859.
32. Monagas, M., Urpi-Sarda, M., Sanchez-Patan, F., Llorach, R. et al., Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010, 1, 233-253.
33. Rechner, A. R., Smith, M. A., Kuhnle, G., Gibson, G. R. et al., Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004, 36, 212-225.
34. Hidalgo, M., Oruna-Concha, M. J., Kolida, S., Walton, G. E. et al., Metabolism of anthocyanins by human gut microflora and their influence on gut bacterial growth. J. Agric. Food Chem. 2012, 60, 3882-3890.
35. Zamora-Ros, R., Rabassa, M., Cherubini, A., Urpi-Sarda, M. et al., Comparison of 24-h volume and creatinine-corrected total urinary polyphenol as a biomarker of total dietary polyphenols in the Invecchiare InCHIANTI study. Anal. Chim. Acta 2011, 704, 110-115.
36. Spencer, J. P., Abd El Mohsen, M. M., Minihane, A. M., Mathers, J. C., Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br. J. Nutr. 2008, 99, 12-22.
37. Warrack, B. M., Hnatyshyn, S., Ott, K. H., Reily, M. D. et al., Normalization strategies for metabonomic analysis of urine samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 547-552.
38. Ma, Y., Li, P. B., Chen, D. W., Fang, T. Z. et al., LC/MS/MS quantitation assay for pharmacokinetics of naringenin and double peaks phenomenon in rats plasma. Int. J. Pharm. 2006, 307, 292-299.
39. Natsume, M., Osakabe, N., Yasuda, A., Baba, S. et al., In vitro antioxidative activity of (-)-epicatechin glucuronide metabolites present in human and rat plasma. Free Radic. Res. 2004, 38, 1341-1348.
40. Piazzon, A., Vrhovsek, U., Masuero, D., Mattivi, F. et al., Antioxidant activity of phenolic acids and their metabolites: synthesis and antioxidant properties of the sulfate derivatives of ferulic and caffeic acids and of the acyl glucuronide of ferulic acid. J. Agric. Food Chem. 2012, 60, 12312-12323.
41. Takagaki, A., Otani, S., Nanjo, F., Antioxidative activity of microbial metabolites of (-)-epigallocatechin gallate produced in rat intestines. Biosci. Biotechnol. Biochem. 2011, 75, 582-585.
42. Unno, T., Tamemoto, K., Yayabe, F., Kakuda, T., Urinary excretion of 5-(3', 4'-dihydroxyphenyl)-gamma-valerolactone, a ring-fission metabolite of (-)-epicatechin, in rats and its in vitro antioxidant activity. J. Agric. Food Chem. 2003, 51, 6893-6898.
43. Duenas, M., Gonzalez-Manzano, S., Gonzalez-Paramas, A., Santos-Buelga, C., Antioxidant evaluation of O-methylated metabolites of catechin, epicatechin and quercetin. J. Pharm. Biomed. Anal. 2010, 51, 443-449.
44. Basu-Modak, S., Gordon, M. J., Dobson, L. H., Spencer, J. P. et al., Epicatechin and its methylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts. Free Radic. Biol. Med. 2003, 35, 910-921.
45. Steffen, Y., Gruber, C., Schewe, T., Sies, H., Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys. 2008, 469, 209-219.
46. Grimm, T., Schafer, A., Hogger, P., Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol). Free Radic. Biol. Med. 2004, 36, 811-822.
47. Tarozzi, A., Morroni, F., Hrelia, S., Angeloni, C. et al., Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. Neurosci. Lett. 2007, 424, 36-40.
48. Oleaga, C., Ciudad, C. J., Izquierdo-Pulido, M., Noe, V., Cocoa flavanol metabolites activate HNF-3beta, Sp1, and NFY-mediated transcription of apolipoprotein AI in human cells. Mol. Nutr. Food Res. 2013, 57, 986-995.
49. Khan, N., Monagas, M., Andres-Lacueva, C., Casas, R. et al., Regular consumption of cocoa powder with milk increases HDL cholesterol and reduces oxidized LDL levels in subjects at high-risk of cardiovascular disease. Nutr. Metab. Cardiovasc. Dis. 2012, 22, 1046-1053.
50. Hoshino, J., Park, E. J., Kondratyuk, T. P., Marler, L. et al., Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J. Med. Chem. 2010, 53, 5033-5043.
51. Miksits, M., Wlcek, K., Svoboda, M., Kunert, O. et al., Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells. Planta Med. 2009, 75, 1227-1230.
52. Urpi-Sarda, M., Monagas, M., Khan, N., Llorach, R. et al., Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2009, 1216, 7258-7267.
53. Williamson, G., Clifford, M. N., Colonic metabolites of berry polyphenols: the missing link to biological activity? Br. J. Nutr. 2010, 104(Suppl 3), S48-S66.
54. Zamora-Ros, R., Urpi-Sarda, M., Lamuela-Raventos, R. M., Estruch, R. et al., Resveratrol metabolites in urine as a biomarker of wine intake in free-living subjects: the PREDIMED study. Free Radic. Biol. Med. 2009, 46, 1562-1566.
55. Mennen, L. I., Sapinho, D., Ito, H., Bertrais, S. et al., Urinary flavonoids and phenolic acids as biomarkers of intake for polyphenol-rich foods. Br. J. Nutr. 2006, 96, 191-198.
56. Natsume, M., Osakabe, N., Oyama, M., Sasaki, M. et al., Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radic. Biol. Med. 2003, 34, 840-849.
57. Baba, S., Osakabe, N., Natsume, M., Muto, Y. et al., In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats. J. Nutr. 2001, 131, 2885-2891.
58. Baba, S., Osakabe, N., Natsume, M., Terao, J., Absorption and urinary excretion of procyanidin B2 [epicatechin-(4 beta-8)-epicatechin] in rats. Free Radic. Biol. Med. 2002, 33, 142-148.
59. Kohri, T., Suzuki, M., Nanjo, F., Identification of metabolites of (-)-epicatechin gallate and their metabolic fate in the rat. J. Agric. Food Chem. 2003, 51, 5561-5566.
60. Marczylo, T. H., Cooke, D., Brown, K., Steward, W. P. et al., Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice. Cancer Chemother. Pharmacol. 2009, 64, 1261-1268.
61. Tsuda, T., Horio, F., Osawa, T., Absorption and metabolism of cyanidin 3-O-beta-D-glucoside in rats. FEBS Lett. 1999, 449, 179-182.
62. Ichiyanagi, T., Rahman, M. M., Kashiwada, Y., Ikeshiro, Y. et al., Absorption and metabolism of delphinidin 3-O-beta-D-glucopyranoside in rats. Free Radic. Biol. Med. 2004, 36, 930-937.
63. Silberberg, M., Gil-Izquierdo, A., Combaret, L., Remesy, C. et al., Flavanone metabolism in healthy and tumor-bearing rats. Biomed. Pharmacother. 2006, 60, 529-535.
64. Abd El Mohsen, M., Marks, J., Kuhnle, G., Rice-Evans, C. et al., The differential tissue distribution of the citrus flavanone naringenin following gastric instillation. Free Radic. Res. 2004, 38, 1329-1340.
65. Lan, K., Jiang, X., He, J., Quantitative determination of isorhamnetin, quercetin and kaempferol in rat plasma by liquid chromatography with electrospray ionization tandem mass spectrometry and its application to the pharmacokinetic study of isorhamnetin. Rapid Commun. Mass Spectrom. 2007, 21, 112-120.
66. Moon, Y. J., Wang, L., DiCenzo, R., Morris, M. E., Quercetin pharmacokinetics in humans. Biopharm. Drug Dispos. 2008, 29, 205-217.
67. Loke, W. M., Jenner, A. M., Proudfoot, J. M., McKinley, A. J. et al., A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J. Nutr. 2009, 139, 2309-2314.
68. Kawai, Y., Saito, S., Nishikawa, T., Ishisaka, A. et al., Different profiles of quercetin metabolites in rat plasma: comparison of two administration methods. Biosci. Biotechnol. Biochem. 2009, 73, 517-523.
69. Santos, M. R., Rodriguez-Gomez, M. J., Justino, G. C., Charro, N. et al., Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats. Br. J. Pharmacol. 2008, 153, 1750-1761.
70. Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M. et al., Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1246-1252.
71. Boocock, D. J., Patel, K. R., Faust, G. E., Normolle, D. P. et al., Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 848, 182-187.
72. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E. et al., High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382.
73. Burkon, A., Somoza, V., Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides-two novel resveratrol metabolites in human plasma. Mol. Nutr. Food Res. 2008, 52, 549-557.
74. Meng, X., Maliakal, P., Lu, H., Lee, M. J. et al., Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. J. Agric. Food Chem. 2004, 52, 935-942.
75. Asensi, M., Medina, I., Ortega, A., Carretero, J. et al., Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 2002, 33, 387-398.
76. Gao, S. H., Zhan, Q., Li, J. X., Yang, Q. et al., LC-MS/MS method for the simultaneous determination of ethyl gallate and its major metabolite in rat plasma. Biomed. Chromatogr. 2010, 24, 472-478.
77. Rondini, L., Peyrat-Maillard, M. N., Marsset-Baglieri, A., Berset, C., Sulfated ferulic acid is the main in vivo metabolite found after short-term ingestion of free ferulic acid in rats. J. Agric. Food Chem. 2002, 50, 3037-3041.
78. Visioli, F., Galli, C., Grande, S., Colonnelli, K. et al., Hydroxytyrosol excretion differs between rats and humans and depends on the vehicle of administration. J. Nutr. 2003, 133, 2612-2615.
79. Fardet, A., Llorach, R., Orsoni, A., Martin, J. F. et al., Metabolomics provide new insight on the metabolism of dietary phytochemicals in rats. J. Nutr. 2008, 138, 1282-1287.
80. Nurmi, T., Mursu, J., Heinonen, M., Nurmi, A. et al., Metabolism of berry anthocyanins to phenolic acids in humans. J. Agric. Food Chem. 2009, 57, 2274-2281.
81. Ichiyanagi, T., Shida, Y., Rahman, M. M., Hatano, Y. et al., Metabolic pathway of cyanidin 3-O-beta-D-glucopyranoside in rats. J. Agric. Food Chem. 2005, 53, 145-150.
82. Liu, M., Zou, W., Yang, C., Peng, W. et al., Metabolism and excretion studies of oral administered naringin, a putative antitussive, in rats and dogs. Biopharm. Drug Dispos. 2012, 33, 123-134.
83. Ávila, M., Hidalgo, M., Sánchez-Moreno, C., Pelaez, C. et al., Bioconversion of anthocyanin glycosides by Bifidobacteria and Lactobacillus. Food Res. Int. 2009, 42, 1453-1461.
84. Nurmi, A., Nurmi, T., Mursu, J., Hiltunen, R. et al., Ingestion of oregano extract increases excretion of urinary phenolic metabolites in humans. J. Agric. Food Chem. 2006, 54, 6916-6923.
85. Hodgson, J. M., Morton, L. W., Puddey, I. B., Beilin, L. J. et al., Gallic acid metabolites are markers of black tea intake in humans. J. Agric. Food Chem. 2000, 48, 2276-2280.
86. Meng, X., Sang, S., Zhu, N., Lu, H. et al., Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol. 2002, 15, 1042-1050.
87. Rechner, A. R., Kuhnle, G., Bremner, P., Hubbard, G. P. et al., The metabolic fate of dietary polyphenols in humans. Free Radic. Biol. Med. 2002, 33, 220-235.
88. Jung, C. M., Heinze, T. M., Schnackenberg, L. K., Mullis, L. B. et al., Interaction of dietary resveratrol with animal-associated bacteria. FEMS Microbiol. Lett. 2009, 297, 266-273.
89. Roowi, S., Stalmach, A., Mullen, W., Lean, M. E. et al., Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J. Agric. Food Chem. 2010, 58, 1296-1304.
90. Olthof, M. R., Hollman, P. C., Buijsman, M. N., van Amelsvoort, J. M. et al., Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 2003, 133, 1806-1814.
91. Mathew, S., Abraham, T. E., Bioconversions of ferulic acid, an hydroxycinnamic acid. Crit. Rev. Microbiol. 2006, 32, 115-125.
92. Zhang, Z. C., Xu, M., Sun, S. F., Qiao, X. et al., Metabolic analysis of four phenolic acids in rat by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 871, 7-14.
93. Rice-Evans, C. A., Miller, N. J., Paganga, G., Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20, 933-956.
94. Tuck, K. L., Hayball, P. J., Major phenolic compounds in olive oil: metabolism and health effects. J. Nutr. Biochem. 2002, 13, 636-644.
95. Appeldoorn, M. M., Vincken, J. P., Aura, A. M., Hollman, P. C. et al., Procyanidin dimers are metabolized by human microbiota with 2-(3, 4-dihydroxyphenyl)acetic acid and 5-(3, 4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. J. Agric. Food Chem. 2009, 57, 1084-1092.
96. Dall'Asta, M., Calani, L., Tedeschi, M., Jechiu, L. et al., Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. Nutrition 2012, 28, 197-203.
97. Meselhy, M. R., Nakamura, N., Hattori, M., Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria. Chem. Pharm. Bull. (Tokyo) 1997, 45, 888-893.
98. Aura, A. M., Martin-Lopez, P., O'Leary, K. A., Williamson, G. et al., In vitro metabolism of anthocyanins by human gut microflora. Eur. J. Nutr. 2005, 44, 133-142.
99. Gao, K., Xu, A., Krul, C., Venema, K. et al., Of the major phenolic acids formed during human microbial fermentation of tea, citrus, and soy flavonoid supplements, only 3, 4-dihydroxyphenylacetic acid has antiproliferative activity. J. Nutr. 2006, 136, 52-57.
100. Aura, A. M., O'Leary, K. A., Williamson, G., Ojala, M. et al., Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J. Agric. Food Chem. 2002, 50, 1725-1730.